-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Topical -X- _ O
0.12 -X- _ O
% -X- _ O
chlorhexidine -X- _ O
has -X- _ O
been -X- _ O
used -X- _ O
widely -X- _ O
to -X- _ O
prevent -X- _ O
ventilator- -X- _ O
associated -X- _ O
pneumonia -X- _ O
in -X- _ O
patients -X- _ O
undergoing -X- _ O
mechanical -X- _ O
ventilation. -X- _ O
However -X- _ O
, -X- _ O
it -X- _ O
is -X- _ O
not -X- _ O
approved -X- _ O
for -X- _ O
mucosal -X- _ O
application -X- _ O
in -X- _ O
Japan. -X- _ O
The -X- _ O
aims -X- _ O
of -X- _ O
this -X- _ O
study -X- _ O
were -X- _ O
to -X- _ O
investigate -X- _ O
if -X- _ O
topical -X- _ B-Intervention
povidone -X- _ I-Intervention
iodine -X- _ I-Intervention
( -X- _ O
i -X- _ O
) -X- _ O
inhibits -X- _ O
bacterial -X- _ O
growth -X- _ O
and -X- _ O
( -X- _ O
ii -X- _ O
) -X- _ O
disrupts -X- _ O
the -X- _ O
balance -X- _ O
of -X- _ O
the -X- _ O
oral -X- _ O
microbiota. -X- _ O
METHODS -X- _ O
: -X- _ O
This -X- _ O
randomized -X- _ O
controlled -X- _ O
clinical -X- _ O
trial -X- _ O
included -X- _ O
23 -X- _ B-Patient
patients -X- _ I-Patient
who -X- _ I-Patient
underwent -X- _ I-Patient
mechanical -X- _ I-Patient
ventilation -X- _ I-Patient
in -X- _ O
the -X- _ O
intensive -X- _ O
care -X- _ O
unit. -X- _ O
The -X- _ O
patients -X- _ O
were -X- _ O
divided -X- _ O
randomly -X- _ O
into -X- _ O
two -X- _ O
groups -X- _ O
: -X- _ O
the -X- _ O
intervention -X- _ B-Intervention
group -X- _ I-Intervention
( -X- _ I-Intervention
n -X- _ I-Intervention
= -X- _ I-Intervention
16 -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ O
the -X- _ B-Comparison
control -X- _ I-Comparison
group -X- _ I-Comparison
( -X- _ I-Comparison
n -X- _ I-Comparison
= -X- _ I-Comparison
7 -X- _ I-Comparison
) -X- _ I-Comparison
. -X- _ O
All -X- _ O
patients -X- _ O
received -X- _ O
oral -X- _ O
cleaning -X- _ O
with -X- _ O
3 -X- _ O
% -X- _ O
hydrogen -X- _ O
peroxide -X- _ O
, -X- _ O
followed -X- _ O
by -X- _ O
irrigation -X- _ O
with -X- _ O
tap -X- _ O
water. -X- _ O
The -X- _ O
patients -X- _ B-Intervention
in -X- _ I-Intervention
the -X- _ I-Intervention
intervention -X- _ I-Intervention
group -X- _ I-Intervention
received -X- _ I-Intervention
10 -X- _ I-Intervention
% -X- _ I-Intervention
povidone -X- _ I-Intervention
iodine -X- _ I-Intervention
applied -X- _ O
topically -X- _ O
to -X- _ O
the -X- _ O
oral -X- _ O
cavity. -X- _ O
The -X- _ O
concentration -X- _ O
of -X- _ O
total -X- _ O
bacteria -X- _ O
in -X- _ O
the -X- _ O
oropharyngeal -X- _ O
fluid -X- _ O
were -X- _ O
determined -X- _ O
before -X- _ O
, -X- _ O
immediately -X- _ O
after -X- _ O
, -X- _ O
1 -X- _ O
h -X- _ O
, -X- _ O
2 -X- _ O
h -X- _ O
, -X- _ O
and -X- _ O
3 -X- _ O
h -X- _ O
after -X- _ O
oral -X- _ O
care -X- _ O
using -X- _ O
the -X- _ O
Rapid -X- _ O
Oral -X- _ O
Bacteria -X- _ O
Quantification -X- _ O
System -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
based -X- _ O
on -X- _ O
dielectrophoresis -X- _ O
and -X- _ O
impedance -X- _ O
measurements. -X- _ O
The -X- _ O
number -X- _ O
of -X- _ O
streptococci -X- _ O
, -X- _ O
methicillin- -X- _ O
resistant -X- _ O
Staphylococcus -X- _ O
aureus -X- _ O
, -X- _ O
Streptococcus -X- _ O
pneumoniae -X- _ O
, -X- _ O
Pseudomonas -X- _ O
aeruginosa -X- _ O
, -X- _ O
Porphyromonas -X- _ O
gingivalis -X- _ O
, -X- _ O
and -X- _ O
Candida -X- _ O
albicans -X- _ O
before -X- _ O
, -X- _ O
immediately -X- _ O
after -X- _ O
, -X- _ O
1 -X- _ O
h -X- _ O
, -X- _ O
and -X- _ O
3 -X- _ O
h -X- _ O
after -X- _ O
oral -X- _ O
care -X- _ O
were -X- _ O
estimated -X- _ O
based -X- _ O
on -X- _ O
real-time -X- _ O
polymerase -X- _ O
chain -X- _ O
reaction -X- _ O
data. -X- _ O
RESULTS -X- _ O
: -X- _ O
After -X- _ B-Outcome
irrigation -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
oral -X- _ I-Outcome
cavity -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
number -X- _ I-Outcome
of -X- _ I-Outcome
bacteria -X- _ I-Outcome
decreased -X- _ I-Outcome
, -X- _ I-Outcome
but -X- _ I-Outcome
increased -X- _ I-Outcome
again -X- _ I-Outcome
at -X- _ I-Outcome
1 -X- _ I-Outcome
h -X- _ I-Outcome
after -X- _ I-Outcome
oral -X- _ I-Outcome
care -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
control -X- _ I-Outcome
group -X- _ I-Outcome
; -X- _ I-Outcome
however -X- _ I-Outcome
, -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
intervention -X- _ I-Outcome
group -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
concentration -X- _ I-Outcome
of -X- _ I-Outcome
bacteria -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
lower -X- _ I-Outcome
than -X- _ I-Outcome
that -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
control -X- _ I-Outcome
group -X- _ I-Outcome
at -X- _ I-Outcome
1 -X- _ I-Outcome
hour -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.009 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
2 -X- _ I-Outcome
h -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.001 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
3 -X- _ I-Outcome
h -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.001 -X- _ I-Outcome
) -X- _ I-Outcome
after -X- _ I-Outcome
oral -X- _ I-Outcome
care. -X- _ I-Outcome
The -X- _ I-Outcome
growth -X- _ I-Outcome
of -X- _ I-Outcome
all -X- _ I-Outcome
bacterial -X- _ I-Outcome
species -X- _ I-Outcome
tested -X- _ I-Outcome
was -X- _ I-Outcome
inhibited -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
intervention -X- _ I-Outcome
group -X- _ I-Outcome
at -X- _ I-Outcome
3 -X- _ I-Outcome
h -X- _ I-Outcome
after -X- _ I-Outcome
oral -X- _ I-Outcome
care -X- _ I-Outcome
, -X- _ I-Outcome
suggesting -X- _ I-Outcome
that -X- _ I-Outcome
povidone -X- _ I-Outcome
iodine -X- _ I-Outcome
did -X- _ I-Outcome
not -X- _ I-Outcome
disturb -X- _ I-Outcome
the -X- _ I-Outcome
balance -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
oral -X- _ I-Outcome
microbiota. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
Topical -X- _ B-Outcome
application -X- _ I-Outcome
of -X- _ I-Outcome
povidone -X- _ I-Outcome
iodine -X- _ I-Outcome
after -X- _ I-Outcome
cleaning -X- _ I-Outcome
and -X- _ I-Outcome
irrigation -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
oral -X- _ I-Outcome
cavity -X- _ I-Outcome
inhibited -X- _ I-Outcome
bacterial -X- _ I-Outcome
growth -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
oropharyngeal -X- _ I-Outcome
fluid -X- _ I-Outcome
of -X- _ I-Outcome
patients -X- _ I-Outcome
on -X- _ I-Outcome
mechanical -X- _ I-Outcome
ventilation -X- _ I-Outcome
while -X- _ I-Outcome
not -X- _ I-Outcome
disrupting -X- _ I-Outcome
the -X- _ I-Outcome
balance -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
oral -X- _ I-Outcome
microbiota. -X- _ I-Outcome
TRIAL -X- _ O
REGISTRATION -X- _ O
: -X- _ O
University -X- _ O
Hospitals -X- _ O
Medical -X- _ O
Information -X- _ O
Network -X- _ O
Clinical -X- _ O
Trials -X- _ O
Registry -X- _ O
( -X- _ O
UMIN-CTR -X- _ O
) -X- _ O
, -X- _ O
UMIN000028307. -X- _ O
Registered -X- _ O
1 -X- _ O
September -X- _ O
2017 -X- _ O
. -X- _ O

